13F HOLDINGS REPORT
Darwin Global Management, Ltd.
Quarter ended Q4 2023 · Filed November 14, 2023 · Accession 0001892688-23-000097
Total Value
$284.2M
Positions
3
Other Managers
0
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | AMBRX BIOPHARMA INC | 02290A102 | 16,688,636 | $191.9M | 67.54% |
| 2 | IMMUNOVANT INC | IMVT | 1,818,371 | $69.8M | 24.57% |
| 3 | ARGENX SE | ARGX | 45,615 | $22.4M | 7.89% |